Estimation of an optimal chemotherapy utilisation rate for colon cancer: An evidence-based benchmark for cancer care

The optimal chemotherapy utilisation rate can serve as an evidence-based benchmark in the planning and evaluation of chemotherapy services. Chemotherapy may be under-utilised in the initial management of patients presenting with metastatic colon cancer.